03/11/2025
5:30 AM | Apogee Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2025
7:01 PM | Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
7:02 PM | Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
12:46 PM | Apogee Therapeutics (Subject)
HENDERSON MICHAEL THOMAS (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
6:06 AM | Apogee Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/03/2025
6:12 AM | Apogee Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/03/2025
5:30 AM | Apogee Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2025
8:00 AM | Apogee Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SCHEDULE 13G | |
02/07/2025
7:01 PM | Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2025
7:02 PM | Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
1:02 PM | Apogee Therapeutics (Subject)
HENDERSON MICHAEL THOMAS (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for APGE and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Apogee Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
02/03/2025
6:05 AM | Apogee Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/31/2025
7:00 PM | Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
7:00 PM | Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
11:23 AM | Apogee Therapeutics (Subject)
HENDERSON MICHAEL THOMAS (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/03/2025
7:00 PM | Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
5:00 AM | Apogee Therapeutics (Issuer)
McKenna Mark C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
7:01 PM | Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
7:01 PM | Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
7:02 PM | Apogee Therapeutics (Issuer)
Henderson Jane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
7:02 PM | Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
3:59 PM | Apogee Therapeutics (Subject)
Dambkowski Carl (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/10/2024
6:30 AM | Apogee Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2024
7:01 PM | Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2024
7:02 PM | Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2024
10:12 AM | Apogee Therapeutics (Subject)
HENDERSON MICHAEL THOMAS (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/02/2024
5:17 AM | Apogee Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
4:46 PM | Apogee Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
10:16 AM | Apogee Therapeutics (Subject)
DRIEHAUS CAPITAL MANAGEMENT LLC (Filed by)
| Form SC 13G | |
11/14/2024
9:18 AM | Apogee Therapeutics (Subject)
Deep Track Capital, LP (Filed by)
| Form SC 13G/A | |
11/12/2024
6:15 AM | Apogee Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/12/2024
6:05 AM | Apogee Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
7:01 PM | Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
7:02 PM | Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
10:39 AM | Apogee Therapeutics (Subject)
HENDERSON MICHAEL THOMAS (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/04/2024
6:59 PM | ACCESS INDUSTRIES MANAGEMENT, LLC (Filed by)
Apogee Therapeutics (Subject)
| Form SC 13G/A | |
10/24/2024
7:10 AM | Apogee Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2024
5:06 PM | Apogee Therapeutics (Subject)
BlackRock, Inc. (Filed by)
| Form SC 13G | |
10/04/2024
7:01 PM | Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
7:02 PM | Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
9:05 AM | Apogee Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G | |
Trump’s Great Society (Ad) Trump’s Final Reset
Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now. Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma |
10/02/2024
3:20 PM | Apogee Therapeutics (Subject)
Dambkowski Carl (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2024
1:34 PM | Apogee Therapeutics (Subject)
HENDERSON MICHAEL THOMAS (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/06/2024
7:02 PM | Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2024
7:03 PM | Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
12:35 PM | Apogee Therapeutics (Subject)
HENDERSON MICHAEL THOMAS (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/23/2024
7:05 PM | Apogee Therapeutics (Issuer)
Henderson Jane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
6:29 AM | Apogee Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
4:25 PM | Apogee Therapeutics (Filer)
| Form S-3ASR | |
08/12/2024
6:00 AM | Apogee Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024
5:35 AM | Apogee Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
7:05 PM | Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
7:05 PM | Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
12:18 PM | Apogee Therapeutics (Subject)
HENDERSON MICHAEL THOMAS (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/05/2024
7:01 PM | Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2024
7:01 PM | Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2024
12:39 PM | Apogee Therapeutics (Subject)
HENDERSON MICHAEL THOMAS (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/03/2024
12:13 PM | Apogee Therapeutics (Subject)
Dambkowski Carl (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2024
7:12 PM | Apogee Therapeutics (Issuer)
JONES WILLIAM A JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
7:00 PM | Apogee Therapeutics (Issuer)
Fairmount Funds Management LLC (Reporting)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
7:01 PM | Apogee Therapeutics (Issuer)
Gottesdiener Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
7:02 PM | Apogee Therapeutics (Issuer)
Shah Nimish P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
7:03 PM | Apogee Therapeutics (Issuer)
Fox Jennifer A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
7:04 PM | Apogee Therapeutics (Issuer)
Bollinger Lisa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
7:05 PM | Apogee Therapeutics (Issuer)
McKenna Mark C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
7:05 PM | Apogee Therapeutics (Issuer)
Bollinger Lisa (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/30/2024
7:07 PM | Apogee Therapeutics (Issuer)
Bollinger Lisa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
6:35 AM | Apogee Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/28/2024
6:36 AM | Apogee Therapeutics (Filer)
| Form DEFA14A | |
05/15/2024
3:39 PM | Apogee Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
6:10 AM | Apogee Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/13/2024
6:26 AM | Apogee Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/13/2024
6:05 AM | Apogee Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/24/2024
3:15 PM | Apogee Therapeutics (Filer)
| Form DEF 14A | |
04/24/2024
3:16 PM | Apogee Therapeutics (Filer)
| Form DEFA14A | |
04/24/2024
3:18 PM | Apogee Therapeutics (Filer)
| Form ARS | |
04/01/2024
4:42 PM | Apogee Therapeutics (Subject)
Fairmount Funds Management LLC (Filed by)
| Form SC 13D/A | |
04/01/2024
4:44 PM | Apogee Therapeutics (Issuer)
Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Fairmount Healthcare Fund L.P. (Reporting)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Buy APGE Stock Free APGE Stock Alerts